Halonen Alex, Fan Heidi Sze Lok, Masina Stephanie, Chooniedass Rishma, Keys Elizabeth, Tarrant Marie
School of Nursing, The University of British Columbia, Okanagan Campus, 3333 University Way, Kelowna, BC V1V 1V7, Canada.
School of Nursing, The University of British Columbia, Okanagan Campus, 3333 University Way, Kelowna, BC V1V 1V7, Canada.
Vaccine. 2025 Aug 13;61:127305. doi: 10.1016/j.vaccine.2025.127305. Epub 2025 Jun 3.
COVID-19 vaccine uptake was significantly lower in children under 12 when compared with adults. Vaccine hesitancy was a potential key contributor to the challenges faced in COVID-19 vaccine uptake METHODS: An online cross-sectional survey was conducted across British Columbia, Canada, from October to December 2021 to understand the COVID-19 vaccine perceptions of parents of children under 12 years of age. Participants completed a modified version of the Vaccine Hesitancy Scale (VHS). Logistic regression models were used to identify factors associated with parental vaccine hesitancy and to explore the relationship between parental vaccine intentions and vaccine hesitancy RESULTS: A total of 993 parents participated in the study. One-half of parents (52.1 %) were vaccine hesitant for pediatric COVID-19 vaccines. For every additional child under 12 in a household, parents were more hesitant (adjusted odds ration [aOR] 1.69, 95 % Confidence Interval [CI] 1.28-2.24). Vaccinated parents (aOR 0.01, 95 % CI 0.004-0.02 vs. unvaccinated parents) and parents of children immunized for influenza (aOR 0.18, 95 % CI 0.12-0.29 vs. parents of children not immunized for influenzas) were less likely to be hesitant. Participants who received a COVID-19 vaccine recommendation from their healthcare provider were also less likely to be hesitant (aOR 0.37, 95 % CI 0.18-0.79). Vaccine hesitant parents were less likely to intend to vaccinate their child when compared with a parent who was not vaccine hesitant (aOR 0.001, 95 % CI 0.0004-0.005) CONCLUSION: The findings from this study identify factors influencing COVID-19 vaccine decision-making, supporting the application of the VHS in clinical practice to allow for more strategic implementation of vaccine-promotion resources.
与成年人相比,12岁以下儿童的新冠疫苗接种率显著更低。疫苗犹豫是新冠疫苗接种面临挑战的一个潜在关键因素。方法:2021年10月至12月在加拿大不列颠哥伦比亚省开展了一项在线横断面调查,以了解12岁以下儿童家长对新冠疫苗的看法。参与者完成了一份修改版的疫苗犹豫量表(VHS)。采用逻辑回归模型来确定与家长疫苗犹豫相关的因素,并探讨家长的疫苗接种意愿与疫苗犹豫之间的关系。结果:共有993名家长参与了该研究。一半的家长(52.1%)对儿科新冠疫苗持犹豫态度。家庭中每增加一名12岁以下儿童,家长就更犹豫(调整后的优势比[aOR]为1.69,95%置信区间[CI]为1.28 - 2.24)。接种过疫苗的家长(与未接种疫苗的家长相比,aOR为0.01,95%CI为0.004 - 0.02)以及为孩子接种过流感疫苗的家长(与未为孩子接种流感疫苗的家长相比,aOR为0.18,95%CI为0.12 - 0.29)犹豫的可能性较小。从医疗服务提供者那里获得新冠疫苗接种建议的参与者犹豫的可能性也较小(aOR为0.37,95%CI为0.18 - 0.79)。与不犹豫的家长相比,犹豫的家长为孩子接种疫苗的意愿较低(aOR为0.001,95%CI为0.0004 - 0.005)。结论:本研究结果确定了影响新冠疫苗决策的因素,支持在临床实践中应用疫苗犹豫量表,以便更有策略地实施疫苗推广资源。